{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:30:26Z","timestamp":1794004226918,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Multidisciplinary Innovation Grant in Traditional Chinese Medicine","award":["No. GZKJ2304"],"award-info":[{"award-number":["No. GZKJ2304"]}]},{"name":"Guangxi Health Commission Key Laboratory of Applied Fundamental Research of Zhuang Medicine","award":["Gui Wei Ke Jiao Fa (2020) No. 17"],"award-info":[{"award-number":["Gui Wei Ke Jiao Fa (2020) No. 17"]}]},{"name":"Training Program under the \"139\" Plan for Developing High-level Medical Talent in Guangxi","award":["Gui Wei Ke Jiao Fa (2020) No. 15"],"award-info":[{"award-number":["Gui Wei Ke Jiao Fa (2020) No. 15"]}]},{"name":"Guangxi Higher Education Key Laboratory for the Research of Du-related Diseases in Zhuang Medicine","award":["Gui Jiao Ke Yan (2022) No. 10"],"award-info":[{"award-number":["Gui Jiao Ke Yan (2022) No. 10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01685-4","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:12:33Z","timestamp":1748081553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Network pharmacology and experimental validation to elucidate the mechanism of the treatment of polycystic ovary syndrome with insulin resistance by Resina Draconis"],"prefix":"10.1186","volume":"18","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiusong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"1685_CR1","doi-asserted-by":"publisher","unstructured":"Myers SH, Russo M, Dinicola S, Forte G, Unfer V. Questioning PCOS phenotypes for reclassification and tailored therapy. Trends Endocrinol Metab. 2023;34(11):694\u2013703. https:\/\/doi.org\/10.1016\/j.tem.2023.08.005IF:10.9Q1. Epub 2023 Sep 1. PMID: 37661546IF: 10.9 Q1.","DOI":"10.1016\/j.tem.2023.08.005IF:10.9Q1"},{"key":"1685_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167\u201375. Epub 2019 Apr 25. PMID: 31029778.","journal-title":"Life Sci"},{"key":"1685_CR3","doi-asserted-by":"crossref","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030. doi: 10.1210\/er.2011-1034IF: 20.3 Q1. Epub 2012 Oct 12. PMID: 23065822; PMCID: PMC5393155.","DOI":"10.1210\/er.2011-1034"},{"key":"1685_CR4","doi-asserted-by":"publisher","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940. https:\/\/doi.org\/10.1016\/j.lfs.2019.116940. Epub 2019 Oct 8. PMID: 31604107.","journal-title":"Life Sci"},{"key":"1685_CR5","doi-asserted-by":"publisher","unstructured":"Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev. 1987;8(2):132\u2013\u200941. https:\/\/doi.org\/10.1210\/edrv-8-2-132. PMID: 3301317.","DOI":"10.1210\/edrv-8-2-132"},{"issue":"11","key":"1685_CR6","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1042\/BCJ20160124","volume":"473","author":"J Dupont","year":"2016","unstructured":"Dupont J, Scaramuzzi RJ. Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle. Biochem J. 2016;473(11):1483\u2013501. https:\/\/doi.org\/10.1042\/BCJ20160124. PMID: 27234585; PMCID: PMC4888492.","journal-title":"Biochem J"},{"key":"1685_CR7","doi-asserted-by":"publisher","unstructured":"Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod. 1997;12 Suppl 1:53\u201362. https:\/\/doi.org\/10.1093\/humrep\/12.suppl_1.53IF: 6.1 Q1. PMID: 9403321.","DOI":"10.1093\/humrep\/12.suppl_1.53IF"},{"issue":"8","key":"1685_CR8","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110. https:\/\/doi.org\/10.3390\/ijms23084110. PMID: 35456928; PMCID: PMC9030414.","journal-title":"Int J Mol Sci"},{"key":"1685_CR9","doi-asserted-by":"publisher","unstructured":"Fulghesu AM, Romualdi D, Di Florio C, Sanna S, Tagliaferri V, Gambineri A, Tomassoni F, Minerba L, Pasquali R, Lanzone A. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. Hum Reprod. 2012;27(10):3057-66. https:\/\/doi.org\/10.1093\/humrep\/des262IF: 6.0 Q1. Epub 2012 Jul 10. PMID: 22786777.","DOI":"10.1093\/humrep\/des262IF"},{"key":"1685_CR10","doi-asserted-by":"publisher","unstructured":"Ma F, Qiao L, Yue H, Xie S, Zhou X, Jiang M, Zhang W, Qi J, Wang L, Xu K. Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance. Endocr J. 2008;55(5):943-5. https:\/\/doi.org\/10.1507\/endocrj.k08e-094IF: 1.3 Q4. Epub 2008 Jun 14. PMID: 18552461.","DOI":"10.1507\/endocrj.k08e-094IF"},{"issue":"7","key":"1685_CR11","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.3390\/molecules190710650","volume":"19","author":"JY Fan","year":"2014","unstructured":"Fan JY, Yi T, Sze-To CM, Zhu L, Peng WL, Zhang YZ, Zhao ZZ, Chen HB. A systematic review of the botanical, phytochemical and Pharmacological profile of Dracaena Cochinchinensis, a plant source of the ethnomedicine Dragon\u2019s blood. Molecules. 2014;19(7):10650\u201369. https:\/\/doi.org\/10.3390\/molecules190710650. PMID: 25054444; PMCID: PMC6270834.","journal-title":"Molecules"},{"key":"1685_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00049-016-0212-2","volume":"26","author":"J Jura-Morawiec","year":"2016","unstructured":"Jura-Morawiec J, Tulik M. Dragon\u2019s blood secretion and its ecological significance. Chemoecology. 2016;26:101\u20135. https:\/\/doi.org\/10.1007\/s00049-016-0212-2. Epub 2016 Mar 19. PMID: 27239099; PMCID: PMC4863904.","journal-title":"Chemoecology"},{"key":"1685_CR13","doi-asserted-by":"crossref","unstructured":"Hu CM, Li JS, Cheah KP, Lin CW, Yu WY, Chang ML, Yeh GC, Chen SH, Cheng HW, Choy CS. Effect of Sanguis draconis (a dragon\u2019s blood resin) on streptozotocin- and cytokine-induced \u03b2-cell damage, in vitro and in vivo. Diabetes Res Clin Pract. 2011;94(3):417\u2013\u200925. doi: 10.1016\/j.diabres.2011.08.014IF: 5.1 Q2. Epub 2011 Sep 6. PMID: 21899910.","DOI":"10.1016\/j.diabres.2011.08.014"},{"key":"1685_CR14","doi-asserted-by":"crossref","unstructured":"Hou Z, Zhang Z, Wu H. Effect of Sanguis draxonis (a Chinese traditional herb) on the formation of insulin resistance in rats. Diabetes Res Clin Pract. 2005;68(1):3\u201311. doi: 10.1016\/j.diabres.2004.08.011. PMID: 15811560.","DOI":"10.1016\/j.diabres.2004.08.011"},{"key":"1685_CR15","doi-asserted-by":"publisher","unstructured":"Xu P, Li S, Wu Q, Yang L, Zheng N, Zhu C, Liu P, Li N, Zou L, Loureirin C. from Chinese Dragon\u2019s Blood (Dracaena cochinchinensis S.C. Chen), is a novel selective estrogen receptor \u03b1 modulator with anti-Alzheimer\u2019s disease effects. Fitoterapia. 2023;167:105497. https:\/\/doi.org\/10.1016\/j.fitote.2023.105497. Epub 2023 Apr 3. PMID: 37019369.","DOI":"10.1016\/j.fitote.2023.105497"},{"key":"1685_CR16","doi-asserted-by":"publisher","unstructured":"Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, Liang Q. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306. https:\/\/doi.org\/10.1016\/j.jep.2023.116306IF: 5.4 Q1. Epub 2023 Feb 27. PMID: 36858276.","DOI":"10.1016\/j.jep.2023.116306"},{"issue":"2","key":"1685_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt HHHW. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 2022;43(2):136\u201350. Epub 2021 Dec 9. PMID: 34895945.","journal-title":"Trends Pharmacol Sci"},{"key":"1685_CR18","doi-asserted-by":"publisher","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110\u2013\u200920. https:\/\/doi.org\/10.1016\/S1875-5364(13)60037-0. PMID: 23787177.","DOI":"10.1016\/S1875-5364(13)60037-0"},{"key":"1685_CR19","doi-asserted-by":"publisher","first-page":"154658","DOI":"10.1016\/j.phymed.2023.154658","volume":"111","author":"ZL Duan","year":"2023","unstructured":"Duan ZL, Wang YJ, Lu ZH, Tian L, Xia ZQ, Wang KL, Chen T, Wang R, Feng ZY, Shi GP, Xu XT, Bu F, Ding Y, Jiang F, Zhou JY, Wang Q, Chen YG. Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: network Pharmacology analysis and experimental evidence. Phytomedicine. 2023;111:154658. https:\/\/doi.org\/10.1016\/j.phymed.2023.154658. Epub 2023 Jan 12. PMID: 36706698.","journal-title":"Phytomedicine"},{"key":"1685_CR20","doi-asserted-by":"publisher","first-page":"854796","DOI":"10.3389\/fcimb.2022.854796","volume":"12","author":"H Zhao","year":"2022","unstructured":"Zhao H, Chen R, Zheng D, Xiong F, Jia F, Liu J, Zhang L, Zhang N, Zhu S, Liu Y, Zhao L, Liu X. Modified Banxia Xiexin Decoction ameliorates polycystic ovarian syndrome with insulin resistance by regulating intestinal microbiota. Front Cell Infect Microbiol. 2022;12:854796. https:\/\/doi.org\/10.3389\/fcimb.2022.854796. PMID: 35619648; PMCID: PMC9127304.","journal-title":"Front Cell Infect Microbiol"},{"key":"1685_CR21","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.yrtph.2019.104544","volume":"110","author":"N Zhang","year":"2020","unstructured":"Zhang N, Liu X, Zhuang L, Liu X, Zhao H, Shan Y, Liu Z, Li F, Wang Y, Fang J. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K\/AKT and MAPK pathways. Regul Toxicol Pharmacol. 2020;110:104544.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1685_CR22","doi-asserted-by":"crossref","unstructured":"Qiu S, Wu C, Lin F, Chen L, Huang Z, Jiang Z. Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome. Horm Metab Res. 2009;41(12):880-5. doi: 10.1055\/s-0029-1234119IF: 2.2 Q4. Epub 2009 Aug 19. PMID: 19693748IF: 2.2 Q4.","DOI":"10.1055\/s-0029-1234119"},{"key":"1685_CR23","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.jep.2021.113947","volume":"273","author":"MF Peng","year":"2021","unstructured":"Peng MF, Tian S, Song YG, Li CX, Miao MS, Ren Z, Li M. Effects of total flavonoids from Eucommia ulmoides Oliv. Leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet. J Ethnopharmacol. 2021;273:113947. Epub 2021 Feb 19. PMID: 33617969.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1685_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jep.2013.07.035","volume":"149","author":"F Chen","year":"2013","unstructured":"Chen F, Xiong H, Wang J, Ding X, Shu G, Mei Z. Antidiabetic effect of total flavonoids from Sanguis Draxonis in type 2 diabetic rats. J Ethnopharmacol. 2013;149(3):729\u201336. Epub 2013 Aug 7. PMID: 23933499.","journal-title":"J Ethnopharmacol"},{"key":"1685_CR25","doi-asserted-by":"crossref","unstructured":"Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(1):e142241. doi: 10.1172\/JCI142241. PMID: 33393497; PMCID: PMC7773347.","DOI":"10.1172\/JCI142241"},{"key":"1685_CR26","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol (Lausanne). 2022;13:1091147.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1685_CR27","doi-asserted-by":"publisher","first-page":"9955","DOI":"10.1038\/s41598-020-66471-2IF:4.6Q2","volume":"10","author":"J Du","year":"2020","unstructured":"Du J, Xu Y, Sasada S, Oo AKK, Hassan G, Mahmud H, Khayrani AC, Alam MJ, Kumon K, Uesaki R, Afify SM, Mansour HM, Nair N, Zahra MH, Seno A, Okada N, Chen L, Yan T, Seno M. Signaling inhibitors accelerate the conversion of mouse iPS cells into Cancer stem cells in the tumor microenvironment. Sci Rep. 2020;10(1):9955. https:\/\/doi.org\/10.1038\/s41598-020-66471-2IF:4.6Q2. PMID: 32572057; PMCID: PMC7308356.","journal-title":"Sci Rep"},{"issue":"16","key":"1685_CR28","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.3390\/ijms241612665","volume":"24","author":"A Tsay","year":"2023","unstructured":"Tsay A, Wang JC. The role of PIK3R1 in metabolic function and insulin sensitivity. Int J Mol Sci. 2023;24(16):12665. https:\/\/doi.org\/10.3390\/ijms241612665. PMID: 37628845; PMCID: PMC10454413.","journal-title":"Int J Mol Sci"},{"key":"1685_CR29","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.2147\/DMSO.S421947","volume":"16","author":"F Zhang","year":"2023","unstructured":"Zhang F, Ding Y, Zhang B, He M, Wang Z, Lu C, Kang Y. Analysis of methylome, transcriptome, and lipid metabolites to understand the molecular abnormalities in polycystic ovary syndrome. Diabetes Metab Syndr Obes. 2023;16:2745\u201363. PMID: 37720421; PMCID: PMC10503565.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"11","key":"1685_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10815-007-9156-3","volume":"24","author":"M Goto","year":"2007","unstructured":"Goto M, Iwase A, Ando H, Kurotsuchi S, Harata T, Kikkawa F. PTEN and Akt expression during growth of human ovarian follicles. J Assist Reprod Genet. 2007;24(11):541\u20136. https:\/\/doi.org\/10.1007\/s10815-007-9156-3. Epub 2007 Nov 14. PMID: 17999178; PMCID: PMC3455024.","journal-title":"J Assist Reprod Genet"},{"issue":"14","key":"1685_CR31","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/cells12141830","volume":"12","author":"J Kalous","year":"2023","unstructured":"Kalous J, Aleshkina D, Anger M. A role of PI3K\/Akt signaling in oocyte maturation and early embryo development. Cells. 2023;12(14):1830. https:\/\/doi.org\/10.3390\/cells12141830. PMID: 37508495; PMCID: PMC10378481.","journal-title":"Cells"},{"issue":"3","key":"1685_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169(3):381\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2017.04.001. PMID: 28431241; PMCID: PMC5546324.","journal-title":"Cell"},{"issue":"10","key":"1685_CR33","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/cells8101123","volume":"8","author":"ZR Tang","year":"2019","unstructured":"Tang ZR, Zhang R, Lian ZX, Deng SL, Yu K. Estrogen-Receptor expression and function in female reproductive disease. Cells. 2019;8(10):1123. https:\/\/doi.org\/10.3390\/cells8101123. PMID: 31546660; PMCID: PMC6830311.","journal-title":"Cells"},{"key":"1685_CR34","doi-asserted-by":"publisher","unstructured":"Qiu Z, Dong J, Xue C, Li X, Liu K, Liu B, Cheng J, Huang F. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K\/Akt signaling pathway. J Ethnopharmacol. 2020;250:111965. https:\/\/doi.org\/10.1016\/j.jep.2019.111965IF: 5.4 Q1. Epub 2019 Jun 8. PMID: 31185267.","DOI":"10.1016\/j.jep.2019.111965IF"},{"key":"1685_CR35","doi-asserted-by":"publisher","unstructured":"Kohn AD, Summers SA, Birnbaum MJ, Roth RA. Expression of a constitutively active Akt Ser\/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem. 1996;271(49):31372-8. https:\/\/doi.org\/10.1074\/jbc.271.49.31372. PMID: 8940145.","DOI":"10.1074\/jbc.271.49.31372"},{"issue":"1","key":"1685_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-022-04541-1IF:.9.0Q1","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang W, Wang Z, Zheng N, Yuan F, Li B, Li X, Deng L, Lin M, Chen X, Zhang M. Enhanced Glycolysis in granulosa cells promotes the activation of primordial follicles through mTOR signaling. Cell Death Dis. 2022;13(1):87. https:\/\/doi.org\/10.1038\/s41419-022-04541-1IF:.9.0Q1. PMID: 35087042; PMCID: PMC8795455.","journal-title":"Cell Death Dis"},{"key":"1685_CR37","doi-asserted-by":"publisher","unstructured":"Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362(9389):1017-21. https:\/\/doi.org\/10.1016\/s0140-6736(03)14410-8. PMID: 14522531.","DOI":"10.1016\/s0140-6736(03)14410-8"},{"key":"1685_CR38","doi-asserted-by":"publisher","unstructured":"Reddy P, Shen L, Ren C, Boman K, Lundin E, Ottander U, Lindgren P, Liu YX, Sun QY, Liu K. Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol. 2005;281(2):160\u2013\u200970. https:\/\/doi.org\/10.1016\/j.ydbio.2005.02.013. PMID: 15893970.","DOI":"10.1016\/j.ydbio.2005.02.013"},{"issue":"5630","key":"1685_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1126\/science.1086336IF:.56.9Q1","volume":"301","author":"DH Castrillon","year":"2003","unstructured":"Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003;301(5630):215\u20138. https:\/\/doi.org\/10.1126\/science.1086336IF:.56.9Q1. PMID: 12855809.","journal-title":"Science"},{"issue":"3","key":"1685_CR40","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.18632\/aging.202421","volume":"13","author":"M Tan","year":"2021","unstructured":"Tan M, Cheng Y, Zhong X, Yang D, Jiang S, Ye Y, Ding M, Guan G, Yang D, Zhao X. LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway. Aging. 2021;13(3):4617\u201333. Epub 2021 Jan 20. PMID: 33495419; PMCID: PMC7906173.","journal-title":"Aging"},{"key":"1685_CR41","doi-asserted-by":"publisher","unstructured":"Liu H, Luo LL, Qian YS, Fu YC, Sui XX, Geng YJ, Huang DN, Gao ST, Zhang RL. FOXO3a is involved in the apoptosis of naked oocytes and oocytes of primordial follicles from neonatal rat ovaries. Biochem Biophys Res Commun. 2009;381(4):722-7. https:\/\/doi.org\/10.1016\/j.bbrc.2009.02.138. Epub 2009 Mar 1. PMID: 19258007.","DOI":"10.1016\/j.bbrc.2009.02.138"},{"key":"1685_CR42","doi-asserted-by":"publisher","unstructured":"Hnit SS, Xie C, Yao M, Holst J, Bensoussan A, De Souza P, Li Z, Dong Q. p27(Kip1) signaling: Transcriptional and post-translational regulation. Int J Biochem Cell Biol. 2015;68:9\u201314. https:\/\/doi.org\/10.1016\/j.biocel.2015.08.005IF: 4.0 Q2. Epub 2015 Aug 14. PMID: 26279144.","DOI":"10.1016\/j.biocel.2015.08.005IF"},{"key":"1685_CR43","doi-asserted-by":"publisher","unstructured":"Zhao J, Xu J, Wang W, Zhao H, Liu H, Liu X, Liu J, Sun Y, Dunaif A, Du Y, Chen ZJ. Long non-coding RNA LINC-01572:28 inhibits granulosa cell growth via a decrease in p27 (Kip1) degradation in patients with polycystic ovary syndrome. EBioMedicine. 2018;36:526\u2013538. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.043. Epub 2018 Oct 5. Erratum in: EBioMedicine. 2018;37:563. PMID: 30293818; PMCID: PMC6197751.","DOI":"10.1016\/j.ebiom.2018.09.043"},{"key":"1685_CR44","doi-asserted-by":"publisher","first-page":"154908","DOI":"10.1016\/j.phymed.2023.154908","volume":"117","author":"M Li","year":"2023","unstructured":"Li M, Gao S, Kang M, Zhang X, Lan P, Wu X, Yan X, Dang H, Zheng J. Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K\/Akt pathway. Phytomedicine. 2023;117:154908.","journal-title":"Phytomedicine"},{"key":"1685_CR45","doi-asserted-by":"publisher","first-page":"8587","DOI":"10.1007\/s12010-024-04975-7","volume":"196","author":"Y Hong","year":"2024","unstructured":"Hong Y, Sun X, Lu L. Loureirin B inhibits cervical Cancer development by blocking PI3K\/AKT signaling pathway: network Pharmacology analysis and experimental validation. Appl Biochem Biotechnol. 2024;196:8587\u2013604.","journal-title":"Appl Biochem Biotechnol"},{"key":"1685_CR46","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41598-023-30585-0","volume":"13","author":"Y Lv","year":"2023","unstructured":"Lv Y, Mou Y, Su J, Liu S, Ding X, Yuan Y, Li G, Li G. The inhibitory effect and mechanism of Resina draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis. Sci Rep. 2023;13:3816.","journal-title":"Sci Rep"},{"key":"1685_CR47","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y. Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci. 2017;24:646\u201355.","journal-title":"Reprod Sci"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01685-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:12:36Z","timestamp":1748081556000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1685"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01685-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Guangxi University of Chinese Medicine, Nanning, China. Protocol approval number: DW20240603-142.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}